For a patient on insulin glargine 35 units daily with a rapid‑acting insulin carbohydrate‑to‑insulin ratio of 1 unit per 4 g carbs, who receives 1 mg dexamethasone today only, how should the basal insulin dose and carb ratio be adjusted for today and tomorrow?

Insulin Adjustment for Steroid-Induced Hyperglycemia

For a patient on Lantus 35 units daily with a 1:4 carb ratio who receives 1 mg dexamethasone today only, increase Lantus to approximately 52 units (≈50% increase) for today and tomorrow, tighten the carb ratio to 1:2 or 1:3 for meals during the peak steroid effect (today and tomorrow), then return to baseline Lantus 35 units and 1:4 ratio by day 3.

Today's Adjustments (Day of Dexamethasone)

Basal Insulin (Lantus)

• Increase Lantus from 35 units to 50–55 units (approximately 50% increase) to counteract steroid-induced basal insulin resistance 1.
• The American Diabetes Association supports a 50% basal increase for patients receiving 4 mg dexamethasone; for 1 mg, a proportional 40–50% increase (49–52 units) is appropriate 1.
• Alternatively, add 0.1–0.3 units/kg/day to the usual regimen; for a typical adult (70 kg), this equals 7–21 additional units, making 42–56 units total 1.

Carbohydrate Ratio

• Tighten the carb ratio from 1:4 to approximately 1:2 or 1:3 for the first 24–48 hours, reflecting a ~50–100% increase in mealtime insulin requirement 1, 2.
• Dexamethasone peaks 7–9 hours after administration and persists for at least 24 hours, with greatest glucose elevations in the afternoon and evening 1, 2.
• Prandial insulin may need a 40–60% increase (or more) during the peak steroid effect 1.

Correction Scale

• Implement an intensified correction factor during the steroid effect period 1, 2:
  • Add 2 units for glucose >250 mg/dL
  • Add 4 units for glucose >350 mg/dL
• Check capillary glucose every 4–6 hours for the first 48 hours, emphasizing afternoon/evening readings (4–12 hours after dexamethasone) 1, 2.

Tomorrow's Adjustments (24 Hours Post-Dexamethasone)

Basal Insulin

• Maintain Lantus at 50–52 units if fasting glucose remains >180 mg/dL 1, 2.
• Begin tapering by 10–20% (reduce to 40–45 units) if fasting glucose is 100–140 mg/dL at 24 hours 2.
• Insulin resistance is near maximum at approximately 16 hours post-dose, affecting both basal and prandial needs 1.

Carbohydrate Ratio

• Adjust the carb ratio to approximately 1:2.5 or 1:3 (representing a 30–40% reduction in mealtime insulin from the peak steroid period) 2.
• Monitor pre-meal and 2-hour post-meal glucose to fine-tune this ratio over the next 24 hours 2.

Correction Scale

• Continue the intensified correction scale but expect significantly less need for corrections compared to the first 24 hours 2.

Day 3 Adjustments (48 Hours Post-Dexamethasone)

Basal Insulin

• Decrease Lantus to 18–23 units (approximately 50–65% of the increased dose, or back toward baseline 35 units) as you are now beyond the peak steroid effect 2.
• The European Association for the Study of Diabetes recommends reducing to approximately 50–65% of the increased dose to prevent substantial hypoglycemia risk 2.
• Return to baseline 35 units by day 3 if glucose is well-controlled 2.

Carbohydrate Ratio

• Return the carb ratio from 1:2.5–1:3 to baseline 1:4 as insulin resistance normalizes 2.
• The transition from 24 to 48 hours post-dexamethasone is a high-risk period for hypoglycemia if insulin doses are not appropriately reduced 2.

Correction Scale

• Return to standard correction scale rather than the intensified scale, as insulin sensitivity is returning to baseline 2.

Critical Monitoring Requirements

• Check blood glucose every 4–6 hours for 72 hours after dexamethasone, with particular attention to overnight and fasting values when hypoglycemia risk is highest 1, 2.
• If glucose exceeds 300 mg/dL with nausea, vomiting, or abdominal pain, obtain a ketone measurement immediately 1.
• The most dangerous error is maintaining the increased insulin doses beyond 24–48 hours, as this creates severe hypoglycemia risk when steroid effects dissipate 2.

Safety Considerations

• Never discontinue basal insulin in type 1 diabetes, even when glucose appears controlled, to prevent diabetic ketoacidosis 1.
• Maintaining the increased insulin dose beyond 24–48 hours markedly raises hypoglycemia risk; approximately 75% of inpatient hypoglycemia events are linked to failure to taper basal insulin 1.
• Sliding-scale insulin alone is discouraged by major diabetes guidelines; scheduled basal-bolus adjustments are required for safe glucose control 1.
• Avoid using rapid-acting insulin at bedtime as the sole correction dose, as it increases nocturnal hypoglycemia risk during tapering 1.

Expected Outcomes

• With appropriate basal-bolus modifications for steroid effect, approximately 68% of patients achieve mean glucose <140 mg/dL, versus approximately 38% using inadequate sliding-scale regimens 1.
• Total daily insulin requirements may rise 40–60% above baseline during the peak steroid period (24–48 hours) 1.
• Dexamethasone effects substantially diminish by 48 hours, with insulin requirements declining rapidly once the steroid effect wanes 2.